111514-29-5

Basic information

• Product Name: Benzenesulfonamide, N,N'-1,3-propanediylbis[4-methyl-N-[2-[[(4-methylphenyl)sulfonyl]amino] ethyl]-
• CAS NO: 111514-29-5
• Molecular Formula: C35H44N4O8S4
• Molecular Weight: 777.02
• Mol File: 111514-29-5.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzenesulfonamide, N,N'-1,3-propanediylbis[4-methyl-N-[2-[[(4-methylphenyl)sulfonyl]amino] ethyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonamide, N,N'-1,3-propanediylbis[4-methyl-N-[2-[[(4-methylphenyl)sulfonyl]amino] ethyl]-(111514-29-5)
• EPA Substance Registry System: Benzenesulfonamide, N,N'-1,3-propanediylbis[4-methyl-N-[2-[[(4-methylphenyl)sulfonyl]amino] ethyl]-(111514-29-5)

Safety Data

• Hazardous Substances Data: 111514-29-5(Hazardous Substances Data)

Upstream product

• 4741-99-5 3,7-diazanonane-1,9-diamine 
• 104-15-4 toluene-4-sulfonic acid 
• 7732-18-5 water 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 1068656-63-2 N,N',N'',N'''-tetratosyl-2,5,9,12-tetraaza[13]metacyclophane 
• 1068656-64-3 N,N',N'',N'''-tetratosyl-2,5,9,12-tetraaza[13]paracyclophane 
• 295-37-4 1,4,8,11-Tetraazacyclotetradecane 
• 71089-74-2 1,4,8,11-tetrakis(p-toluenesulphonyl)-1,4,8,11-tetraazacyclotetradecane 
• 118467-56-4 (<(tetrahydro-3'',4'',5'',6''-2''H-pyranyl-2'')oxy>-4'-butyl)-6-tetratosyl-1,4,8,11-tetraaza-1,4,8,11-cyclotetradecane 
• 118467-55-3 (<(tetrahydro-3'',4'',5'',6''-2''H-pyranyl-2)oxy>-2'-ethyl)-6-tetratosyl-1,4,8,11-tetraaza-1,4,8,11-cyclotetradecane 
• 71366-39-7 6-Dodecyl-1,4,8,11-tetrakis-(toluene-4-sulfonyl)-1,4,8,11-tetraaza-cyclotetradecane 
• 139032-25-0 15,16-Dibromo-2,5,9,12-tetra(toluene-p-sulphonyl)-2,3,4,5,6,7,8,9,10,11,12,13-dodecahydro-1H-2,5,9,12-benzotetraazacyclopentadecine 
• 118467-61-1 (tetratosyl-1',4',8',11'-tetraaza-1',4',8',11'-cyclotetradecyl-6')-2-ethyl p-toluenesulfonate 
• 118467-62-2 (tetratosyl-1',4',8',11'-tetraaza-1',4',8',11'-cyclotetradecyl-6')-4-butyl p-toluenesulfonate 
• 118467-65-5 (tetratosyl-1',4',8',11'-tetraaza-1',4',8',11'-cyclotetradecyl-6')-5-pentanenitrile 
• 118467-67-7 <(methylthio)-4'-butyl>-6-tetratosyl-1,4,8,11-tetraaza-1,4,8,11-cyclotetradecane 
• 118467-59-7 (tetratosyl-1',4',8',11'-tetraaza-1',4',8',11'-cyclotetradecyl-6')-4-butanol 
• 118467-64-4 (tetratosyl-1',4',8',11'-tetraaza-1',4',8',11'-cyclotetradecyl-6')-3-propiononitrile 

Relevant articles and documents

SYNTHESIS AND COMPLEXING PROPERTIES OF 1,5,8,12-TETRAKIS(DIHYDROXYPHOSPHORYLMETHYL)-1,5,8,12-TETRAAZACYCLOTETRADECANE, A CYCLOPENDANT PHOSPHORORGANIC COMPLEXON

-

Equilibrium and kinetic properties of CuII cyclophane complexes: The effect of changes in the macrocyclic cavity caused by changes in the substitution at the aromatic ring

The o-B232, m-B232 and p-B232 cyclophanes result from attaching the terminal amine groups of 1,4,8,11-tetraazaundecane (232) to the benzylic carbons of the corresponding o-, m- or p-xylanes. The cavity size of these cyclophanes changes moderately as a con

Methods of preparing manganese complexes of nitrogen-containing macrocyclic ligands

The present invention is directed to low molecular weight mimics of superoxide dismutase (SOD) represented by the formula: STR1 wherein R, R', R1, R'1, R2, R'2, R3, R'3, R4, R'4, R5, R'5, R6, R'6, R7, R'7, R8, R'8, R9, and R'9 and X, Y, Z and n are as defined herein, useful as therapeutic agents for inflammatory disease states and disorders, ischemic/reperfusion injury, stroke, atherosclerosis, hypertension and all other conditions of oxidant-induced tissue damage or injury.